Researchers examined the efficacy of methotrexate vs biologic disease-modifying antirheumatic drugs as protection against cardiovascular disease in rheumatoid arthritis.
Thirty controls were compared with 30 patients with juvenile idiopathic arthritis to determine the link between vitamin D and CVD.
Common rheumatoid arthritis drugs methotrexate and biologics, but not prednisolone, may increase the risk for herpes zoster.
The guideline divides the participants into 5 groups according to HBV serology.
Patients with rheumatoid arthritis and end-stage renal disease have an increased risk for cardiovascular-related death compared with patients without rheumatoid arthritis.
Repeated serum amyloid A measurements could act as an additional marker for monitoring disease activity over time in patients with psoriatic arthritis.
This condition is associated with serious disease flare complicated by sepsis and a high mortality rate.
A hand exercise program in addition to ADL education did not improve ADL ability more than ADL education alone.
Findings suggest that different TNF inhibitor (TNFi) therapies function by alternative mechanisms that affect patient outcomes.
Ultrasound examination of the hands can facilitate the diagnosis of hand osteoarthritis in patients who do not fulfill ACR criteria.
When combined with ultrasound examination, ANG-2 can help lead to the appropriate therapy for JIA.
MOCA is more effective than the Mini-Mental State Examination at detecting cognitive dysfunction.
Cumulative steroid dosage is a risk factor for the development of osteonecrosis.
The majority of patients with systemic lupus erythematosus have poor quality of sleep.
In patients with osteoarthritis, corticosteroid injection was associated with significant hip pain reduction.
Sirukumab, a human monoclonal antibody that selectively binds to the interleukin 6 cytokine with high affinity, can help reduce depressive symptoms in patients with rheumatoid arthritis.
Patients receiving disease-modifying anti-rheumatic drugs (DMARDs) saw no positive dynamics of mental disorders.
The efficacy of lower doses of MTX in patients with rheumatoid arthritis in combination with ADA was studied.
